Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Background: Nontuberculous Mycobacterium infections, particularly Mycobacterium abscessus, are increasingly common among patients with cystic fibrosis and chronic bronchiectatic lung diseases. Treatment is challenging due to intrinsic antibiotic resistance. Bacteriophage therapy represents a potentially novel approach. Relatively few active lytic phages are available and there is great variation in phage susceptibilities among M. abscessus isolates, requiring personalized phage identification. Methods: Mycobacterium isolates from 200 culture-positive patients with symptomatic disease were screened for phage susceptibilities. One or more lytic phages were identified for 55 isolates. Phages were administered intravenously, by aerosolization, or both to 20 patients on a compassionate use basis and patients were monitored for adverse reactions, clinical and microbiologic responses, the emergence of phage resistance, and phage neutralization in serum, sputum, or bronchoalveolar lavage fluid. Results: No adverse reactions attributed to therapy were seen in any patient regardless of the pathogen, phages administered, or the route of delivery. Favorable clinical or microbiological responses were observed in 11 patients. Neutralizing antibodies were identified in serum after initiation of phage delivery intravenously in 8 patients, potentially contributing to lack of treatment response in 4 cases, but were not consistently associated with unfavorable responses in others. Eleven patients were treated with only a single phage, and no phage resistance was observed in any of these. Conclusions: Phage treatment of Mycobacterium infections is challenging due to the limited repertoire of therapeutically useful phages, but favorable clinical outcomes in patients lacking any other treatment options support continued development of adjunctive phage therapy for some mycobacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“successfully used to treat chronic, drug-resistant infections of M. abscessus (177–179)”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [178]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Phages have also been explored as diagnostic tools, and successfully used to treat chronic, drug-resistant infections of M. abscessus (177–179).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [178]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0437-z · Cited by 1,410
Self-citationSchooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Self-citationJault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1125 · Cited by 786
Bustamante, J., Boisson-Dupuis, S., Abel, L., & Casanova, J.-L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.008 · Cited by 684
Phage Therapy for Antibiotic-Resistant Bacterial Infections
Hatfull, G. F., Dedrick, R. M., & Schooley, R. T. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-080219-122208 · Cited by 571
Self-citationSarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., Bourdin, G., McCallin, S., Ngom-Bru, C., Neville, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.023 · Cited by 533
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Aslam, S., Lampley, E., Wooten, D., Karris, M., Benson, C., Strathdee, S., & Schooley, R. T. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa389 · Cited by 342
Self-citationNick, J. A., Dedrick, R. M., Gray, A. L., Vladar, E. K., Smith, B. E., Freeman, K. G., Malcolm, K. C., Epperson, L. E., Hasan, N. A., Hendrix, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.024 · Cited by 251 · cited 1×
“chelonae skin infection (patient 16); details of patients 15 and 16 were recently reported [22, 23].”
BackgroundSelf-citation
Research works printed but not linked: 1
- Guerrero-Bustamante, 2021, Toward a phage cocktail for tuberculosis: susceptibility and tuberculocidal action of mycobacteriophages against diverse Mycobacterium tuberculosis strains, mBio, 12, e00973-21, 10.1128/mbio.00973-21 · DOI · Paper page
Cited by
Items 201–300 of 416
König, H., & Sauter, A. (2023) · Repository KITopen (Karlsruhe Institute of Technology) · doi:10.5445/ir/1000160512 · Cited by 6
The Many Hosts of Mycobacteria 9 (MHM9): A conference report
Klever, A. M., Alexander, K. A., Almeida, D. V., Anderson, M. Z., Ball, R. L., Beamer, G., Boggiatto, P. M., Buikstra, J. E., Chandler, B., Claeys, T. A., et al. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102377 · Cited by 6
Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022
Wu, J., Yang, Y., Yu, J., Qiao, L., Zuo, W., & Zhang, B. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02978-x · Cited by 6
Prevention and control strategies for antibiotic resistance: from species to community level
Wang, Y., Li, H., Chen, Q., Pan, T., Zhu, Y., Springael, D., & Su, J. (2024) · Soil Ecology Letters · doi:10.1007/s42832-023-0222-2 · Cited by 6
Identification of a new antiphage system in Mycobacterium phage ButtersPreprint
Mohammed, H. T., Mageeney, C. M., & Ware, V. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522681 · Cited by 6
O'Connell, L. M., Coffey, A., & O’Mahony, J. (2023) · Viruses · doi:10.3390/v15122290 · Cited by 5
Druszczyńska, M., Sadowska, B., Zabłotni, A., Zhuravska, L., Kulesza, J., & Fol, M. (2025) · Applied Sciences · doi:10.3390/app15158543 · Cited by 5
Next-generation gene therapy for infectious disease: Advances, challenges, and future directions
Fattahi, M., Pirbadami, F., Motallebirad, T., Beheshti, Z., & Azadi, D. (2026) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2026.103164 · Cited by 5
Smooth-to-rough morphotype switching, a mechanism of phage resistance in Mycobacterium abscessus
Liew, J. H., Norman, A., Illouz, M., Teo, T., Ponti, R. D., Hamela, C., Mohan, L., Lew, R., Ron, C., Low, K. E., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2531197123 · Cited by 5
Engineered Bacteriophages: A Next-Generation Platform for Precision Antimicrobials and Therapeutics
Shao, H., Deng, Y., Shi, Y., & Duan, Y. (2026) · Viruses · doi:10.3390/v18030355 · Cited by 5
Laucirica, D. R., Stick, S. M., Garratt, L. W., & Kicic, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1069929 · Cited by 5
Phylogenomics of nontuberculous mycobacteria respiratory infections in people with cystic fibrosis
Bolden, N., Mell, J. C., Bouso, J. M., & Planet, P. J. (2023) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2023.02.001 · Cited by 5
Guo, X., Zhang, J., Wang, Y., Zhou, F., Li, Q. M., & Teng, T. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080406 · Cited by 5
Mirzania, F., Salimikia, I., Yadegari, J. G., Marzban, A., Firouzi, A., Nazarzadeh, A., & Aalaei, J. (2023) · Current Drug Discovery Technologies · doi:10.2174/0115701638284118231220074251 · Cited by 5
Yao, J. C. C., García‐Cehic, D., Quer, J., Méndez, J. N., Dorta‐Gorrín, A., García‐Hevia, L., & Tórtola, T. (2024) · Microorganisms · doi:10.3390/microorganisms12020374 · Cited by 5
SKIN DYSBIOSIS IN ATOPIC DOGS: IS PHAGE THERAPY AN ALTERNATIVE TO ANTIBIOTICS?
Šumonja, I., & Kotnik, T. (2024) · Slovenian Veterinary Research · doi:10.26873/svr-1880-2024 · Cited by 5
New-Generation Antibacterial Agent—Cellulose-Binding Thermostable TP84_Endolysin
Ponikowska, M., Żebrowska, J., & Skowron, P. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313111 · Cited by 4
Avdeev, V. V., Александрович, В. М., Samoilova, A., & Vasileva, I. A. (2025) · PHAGE · doi:10.1089/phage.2024.0066 · Cited by 4
Pardo-Freire, M., Bernabéu-Gimeno, M., Chan, B. K., Turner, P. E., Sánchez‐Romero, I., Pérez, M. A., Iribarren, M. E., & Domingo‐Calap, P. (2025) · ASM Case Reports · doi:10.1128/asmcr.00058-24 · Cited by 4
Shyrokova, L., Egorov, A. A., Cole, A., Duque-Pedraza, J. J., Tyagi, A., Ernits, K., Mets, T., Kurata, T., Juozapaitis, J., Yang, A. L. J., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02274-25 · Cited by 4
Ferreiro‐Posse, A., Boada-Pérez, M., Hatfull, G. F., Revilla‐López, E., Sáez, B., López‐Meseguer, M., Gavaldà, J., Parra, A. P., Roch-Santed, M., Tórtola, T., et al. (2025) · American Journal of Transplantation · doi:10.1016/j.ajt.2025.11.008 · Cited by 4
Self-citationYılmaz, U., Ünlü, M. E., & Vardar‐Ünlü, G. (2026) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2026.107441 · Cited by 4
Breaking multidrug resistance: Rediscovering phage therapy and delivery strategies
Javed, S., Ruggiero, V., Falcone, G., Gaudio, P. D., Aquino, R. P., Auriemma, G., & Russo, P. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108252 · Cited by 4
Chen, N., Yang, Y., Wang, Y., Yao, Y., & Zheng, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156615 · Cited by 4
O'Connell, L. M., Coffey, A., & O’Mahony, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27932 · Cited by 4
Phage therapy: the next frontier in managing periprosthetic joint infection?
Kennedy, I. W., Jones, J. D., & Meek, R. M. D. (2024) · The Bone & Joint Journal · doi:10.1302/0301-620x.106b6.bjj-2023-0878.r2 · Cited by 4
Machine Learning Mediated Advanced Phage and Antimicrobial Therapy- A Futuristic Approach
Mary, A. S., Patil, M. M., Kundu, G., & Rajaram, K. (2023) · Highlights in BioScience · doi:10.36462/h.biosci.202304 · Cited by 4
Phage therapy: A primer for orthopaedic trauma surgeons
Chen, B., Moriarty, T. F., Metsemakers, W., & Chittò, M. (2024) · Injury · doi:10.1016/j.injury.2024.111847 · Cited by 4
Mathematical comparison of protocols for adapting a bacteriophage to a new host
Bull, J. J., & Krone, S. M. (2024) · Virus Evolution · doi:10.1093/ve/veae100 · Cited by 4
Nick, J. A., Martiniano, S. L., Lovell, V. K., Vestal, B. E., Poch, K. R., Caceres, S. M., Rysavy, N., de Moura, V. C., Gilick, J. J., Malcolm, K. C., et al. (2025) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2025.03.669 · Cited by 4
Self-citationComplete genome sequence of Azrael100, a V cluster mycobacteriophage
Machowski, E. E., Ealand, C. S., Jacobs, O., & Kana, B. D. (2023) · Microbiology Resource Announcements · doi:10.1128/mra.00684-23 · Cited by 4
Phage Therapy for Mycobacteria: Overcoming Challenges, Unleashing Potential
Opperman, C. J., & Brink, A. J. (2025) · Infectious Disease Reports · doi:10.3390/idr17020024 · Cited by 4
Binding activity and specificity of tail fiber protein 35Q for Salmonella pullorum
Deng, H., Feng, L., Shi, K., & Du, R. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1429504 · Cited by 3
Cryo-EM Reveals Structural Diversity in Prolate-headed Mycobacteriophage Mycofy1
Li, X., Shao, Q., Li, L., Xie, L., Ruan, Z., & Fang, Q. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169126 · Cited by 3
Human Gut Bacteriophageome: Insights Into Drug Resistance Mechanisms in Tuberculosis
Jafari, E., Azizian, R., Tabasi, M., Banakar, M., & Lankarani, K. B. (2025) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/ipid/8811027 · Cited by 3
Xiang, X., Jin, X., Yang, Q., Zou, L., Wang, Y., Wang, T., & Sun, X. (2025) · Pathogens · doi:10.3390/pathogens14111102 · Cited by 3
Amplification, purification, and lyophilization of mycobacteriophages for therapeutic use
Viland, M., Abad, L., Jacobs‐Sera, D., Freeman, K. G., Russell, D. A., Garlena, R. A., Mowry, E., Yu, S., Lauer, M. J., Vehring, R., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02277-25 · Cited by 3
Self-citationShitikov, E. A., Malakhova, M. V., Kuznetsova, S., Bespiatykh, D., Gorodnichev, R. B., Kiselev, S., Kornienko, M. A., Klimina, K. M., Strokach, A. A., German, A., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1713073 · Cited by 3
Ash, A., Moon, C., & Jang, J. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2509.09030 · Cited by 3
Mycobacterium abscessus research: learning from challenges
Treen, R. Z., Juarrero, M. G., Jackson, M., Lapierre, P., Kremer, L., Ghosh, P., & Ojha, A. K. (2026) · Journal of Bacteriology · doi:10.1128/jb.00436-25 · Cited by 3
Liu, Y., Zhao, H., Cao, X., Jiang, S., Fu, J., Xue, J., Li, C., Xu, Z., Li, M., & Du, W. (2026) · Nature Communications · doi:10.1038/s41467-026-75746-7 · Cited by 3
Gorodnichev, R. B., Kornienko, M. A., Bespiatykh, D., Malakhova, M. V., Krivulia, A. O., Veselovsky, V. A., Bespyatykh, J., Goloshchapov, O. V., Chernenkaya, T. V., & Shitikov, E. A. (2023) · Medicine of Extreme Situations · doi:10.47183/mes.2023.060 · Cited by 3
Characterization of a new Pseudomonas aeruginosa Queuovirinae bacteriophage
Whiteley, L. E., & Whiteley, M. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03719-23 · Cited by 3
The application value of bacteriophage in patients with severe drug-resistant bacterial infections
Chen, J., & Huang, M. (2024) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-24-00022 · Cited by 3
The Application of DNA Viruses to Biotechnology
Schieferecke, A. J., Ralph, N. K., & Schaffer, D. V. (2025) · Viruses · doi:10.3390/v17030414 · Cited by 3
Insight into Bacteriophage Therapy for Bacterial Infections and Cancer
De, P., Bhat, V. G., Kamath, V., Kolathur, K. K., & Mazumder, N. (2025) · Molecular Biotechnology · doi:10.1007/s12033-025-01466-w · Cited by 3
Expression and application of a novel Holin Hol6A3 in phage PD6A3 of Acinetobacter baumannii
Wu, M., Yang, Y., Wang, H., Wang, B., Pan, B., Xie, Y., & Guo, W. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04176-0 · Cited by 3
Zillmann, H. (2025) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-025-04056-y · Cited by 3
Plunder, S., Lauer, U. M., Helling, T., Venturelli, S., & Marongiu, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1040457 · Cited by 3
Weiss, S. M., Happy, K. K., Baliraine, F. W., Beach, A. K., Brobston, S. M., Martinez, C. P., Menard, K. J., Orton, S. M., Salazar, A. L., Frederick, G. D., et al. (2023) · Microbiology Resource Announcements · doi:10.1128/mra.00335-23 · Cited by 3
Genomic analysis of five new mycobacteriophages belonging to the F, G, K, and P clusters
Arora, R., Das, R., Nadar, K., & Bajpai, U. (2025) · 3 Biotech · doi:10.1007/s13205-025-04426-y · Cited by 2
P3MA: A Promising Mycobacteriophage Infecting Mycobacterium abscessus
Broncano-Lavado, A., Aguilera-Correa, J. J., Roquet, F., Kremer, L., Mediero, A., Seoane‐Blanco, M., van Raaij, M. J., Pagán, I., Esteban, J., & García‐Quintanilla, M. (2025) · Antibiotics · doi:10.3390/antibiotics14080801 · Cited by 2
Inactivating conditions of therapeutic mycobacteriophages
Wiggins, A. G., Chaudhry, U., Bisaro, F., Lueck, A., Schmalstig, A. A., Hatfull, G. F., Hill, D. B., & Braunstein, M. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02655-25 · Cited by 2
Self-citationModeling the Phage Properties Best for Therapy
Bull, J. J., Kaur, G., & Krone, S. M. (2026) · Viruses · doi:10.3390/v18020240 · Cited by 2
Johnston, A. M., Rider, N. L., Freeman, A. F., Holland, S. M., Orange, J. S., Platt, C. D., Anglero, A. C., Tsoulis, M. W., Zinn, D., Passarelli, P., et al. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.02.026 · Cited by 2
Terzi, I., Drakopanagiotakis, F., & Rafailidis, P. I. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.108789 · Cited by 2
Zaychikova, M. V., Avdeev, V. V., Kuznetsova, S., Malakhova, M. V., & Shitikov, E. A. (2026) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-bda-18100 · Cited by 2
Connecting the dots between phage pharmacokinetics, pharmacodynamics and immune interactions
Khafagy, E., Rajab, A. A. H., Saqr, A. A., & Hegazy, W. A. H. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108592 · Cited by 2
Bacteriophage inactivation to prevent carry-over in preclinical assays with mycobacteria
Torres, M. P., Morrow, C., Guerrero-Bustamante, C. A., Hatfull, G. F., Diacon, A. H., van Ingen, J., & Janssen, S. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05431-8 · Cited by 2
Self-citationA consensus-based guideline for personalized bacteriophage therapy
Würstle, S. M., Lieberknecht-Jouy, S. C., Duechting, A., Lößner, H., Ceyssens, P., Pirnay, J., de Jode, M., McCallin, S. E., Leitner, L., Willy, C., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04654-6 · Cited by 2
How to: assess patient suitability for unlicensed phage therapy in the United Kingdom
Jones, J. D., Stacey, H. J., Kennedy, I. W., Merabishvili, M., Haines, M. E., Blocker, O., Dharmasena, K., Gordon, A., Hamilton, S. A., Aggarwal, I., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.07.022 · Cited by 2
Antibiotic Resistance in Mycobacteria
Zeng, J., Tan, X., & Gao, C. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007462 · Cited by 2
Bacteriophage Therapy for Chronic Mastoiditis
Casazza, J. A., Tan, D. T. H., Newcomer, M., Sakano, H., Isaacson, B. B., & Hunter, J. B. (2025) · Otology & Neurotology · doi:10.1097/mao.0000000000004417 · Cited by 2
Mohammed, H. T., Mageeney, C. M., Korenberg, J. B., Graham, L. H., & Ware, V. C. (2023) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkad210 · Cited by 2
Respiratory Delivery of Bacteriophages for the Treatment of Lung Infections
Byun, A. S., Chan, H., & Kwok, P. C. L. (2023) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-47567-2_8 · Cited by 2
The changing landscape of infections in the lung transplant recipient
Lum, J., & Koval, C. E. (2024) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001060 · Cited by 2
Yahia, N. M. B., Shan, M., Zhu, Y. F., Yang, Y., Zhang, S., & Yang, Y. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae208 · Cited by 2
Hou, C., Wang, X., Guo, J., Qi, C., Zhang, Y., Chen, Y., Feng, J., Zhao, B., & Li, F. (2024) · FEMS Microbiology Letters · doi:10.1093/femsle/fnae076 · Cited by 2
Lynch, S. A., Sinclair, H., Khatami, A., Mileham, N., Sacher, J., Zheng, J., Lin, R. C. Y., & Iredell, J. R. (2025) · Sustainable Microbiology · doi:10.1093/sumbio/qvae036 · Cited by 2
Self-citationGenome sequence of Mycobacterium abscessus phage P3MA
Broncano-Lavado, A., Roquet, F., Kremer, L., Russell, D. A., Jacobs‐Sera, D., Reidy, T. G., Aguilera-Correa, J. J., Esteban, J., Hatfull, G. F., & García‐Quintanilla, M. (2025) · Microbiology Resource Announcements · doi:10.1128/mra.00169-25 · Cited by 2
Self-citationIsolation of a Peptide That Binds to Pseudomonas aeruginosa Lytic Bacteriophage
Chan, S. K., Zhao, Z., Penziner, S., Khong, E., Pride, D. T., Schooley, R. T., & Steinmetz, N. F. (2022) · ACS Omega · doi:10.1021/acsomega.2c05539 · Cited by 2
Self-citationPhagothérapie pour traiter les infections respiratoires
Mitropoulou, G., Gijs, P.-J., Koutsokera, A., Sauty, A., Blanchon, S., Csajka, C., Brunet, J.-F., Resch, G., Guery, B. P., & von Garnier, C. (2022) · JMIG · doi:10.53738/revmed.2022.18.804.2150 · Cited by 2
Phage therapy to combat mycobacterial infections: a therapeutic perspective
Gupta, S. K., SHARMA, A., Kaur, R., Goel, A., & Singh, S. V. (2024) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.23.03019-5 · Cited by 2
Non-Tuberculous Mycobacterial Pulmonary Disease—Where are we Now?
Kumar, K., & Loebinger, M. R. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.07.001 · Cited by 2
Larsson, S. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/180359 · Cited by 2
Actinobacteriophage Inteins: Host Diversity, Local Dissemination, and Non-Canonical ArchitecturePreprint
Gosselin, S. P., Arsenault, D., & Gogarten, J. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.02.630785 · Cited by 2
Role of Phages in Past Molecular Biology and Potentially in Future Biomedicine
Serwer, P. (2025) · Encyclopedia · doi:10.3390/encyclopedia5020058 · Cited by 2
Likely role of promoter reconstitution in Mpr-mediated D29 resistance by Mycobacterium smegmatisPreprint
Yusuf, B., Ju, Y., Zhou, B., Malik, A., Alam, M. S., Li, L., Tadesse, H. A., Mulu, B. A., Fang, C., Tian, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.27.708680 · Cited by 2
Yee, W., Banta, A. B., Ward, R. D., Musunuri, S., Liu, M.-Y., Huiting, E. D., Gordeeva, J., Letham, S. C., Bharat, T. A. M., Peters, J. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.18.732992 · Cited by 2
Host-phage interactions and modeling for therapy
Williams, J., Burton, N., Dhanoa, G. K., & Sagona, A. P. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.03.010 · Cited by 1
McSweeney, T. D., Chang, M. H., Patel, P., & Nori, P. (2023) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2023.07.001 · Cited by 1
Albert, J. D., Daley, C. L., & Lin, P. L. (2024) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piae003 · Cited by 1
Velasco, R. G., Garza-Manero, S., Pastelin‐Palacios, R., & Moreno‐Eutímio, M. A. (2024) · Educación Química · doi:10.22201/fq.18708404e.2024.3.86725 · Cited by 1
Survey of Thirteen Novel Pseudomonas putida Bacteriophages
Anderson, S., Persinger, R. D., Patel, A., Rupe, E., Osu, J., Cooper, K. I., Lehman, S. M., Kongari, R. R., Jaryenneh, J. D., Mageeney, C. M., et al. (2025) · Applied Microbiology · doi:10.3390/applmicrobiol5040108 · Cited by 1
Williams, S. C. P. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2530455122 · Cited by 1
Bacteriophage therapy targeting microbiome in HIV/AIDS
Zhou, Y., Xu, P., Liu, D., He, Z., Lin, Z., Dai, X., Dai, G., Zhang, L., Chen, Y., Zhao, P., et al. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001373 · Cited by 1
Kim, H. W., Yoon, H. S., Whang, J., & Kim, J.-S. (2026) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2026.102908 · Cited by 1
Phage Therapy in Gastrointestinal Diseases: Current Status and Challenges
Zhang, S., & Zhang, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083662 · Cited by 1
Phage Φ170 biocontrol of multidrug-resistant Vibrio parahaemolyticus in a zebrafish model
Lin, W., Ye, L., Wang, X. E., Ren, J., Xue, F., Dai, J., & Tang, F. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00089-26 · Cited by 1
Exploring the next “phage” of treating non-tuberculous mycobacterial infections
Kevane-Campbell, M., Idris, R., Würstle, S. M., Lieberknecht-Jouy, S. C., Vehreschild, M. J. G. T., Wichelhaus, T. A., & Wetzstein, N. (2026) · Infection · doi:10.1007/s15010-026-02818-7 · Cited by 1
Tewary, S. K., Wang, C.-H., Lin, M.-C., Shen, M. C., Tsai, L.-A., Maharana, J., Perez, R. J., Mou, C.-E., Hatfull, G. F., Lowary, T. L., et al. (2026) · Nature Communications · doi:10.21203/rs.3.rs-9616548/v1 · Cited by 1
Self-citationThornton, C. S., Schaupp, L., Tunney, M. M., & Mall, M. A. (2026) · European Respiratory Journal · doi:10.1183/13993003.00239-2026 · Cited by 1
Agarwalla, S. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-04980-w · Cited by 1
Štilec, V., Marušić, M., Motaln, H., Gregorič, K., Draksler, U., Čater, M., Izlakar, J., Janež, N., Trebše, R., Horvat, S., et al. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05561-x · Cited by 1
Arya, R., Ma, D., Rempuszewski, J., Sadaka, N. M., Frear, A. J., Knapick, B. A., Parker, D. M., Cooper, V. S., Tyne, D. V., Shah, N. B., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74326-z · Cited by 1
Xu, J. F., Shen, J., Chen, S., Chen, J., Liu, X., Gao, F., & Zhang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1873405 · Cited by 1
Shi, Y., Li, J., Yang, Q., Li, J., Li, L., Liu, J., Dai, J., Shang, Y., Zhou, X., Yang, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75735-w · Cited by 1
Sharma, R., Mahadevan, R., Divyash, S., Yeshwante, S., Matcha, S., Cheng, C., Talley, H. S., Schmalstig, A. A., Neupane, P., Maloney, S. E., et al. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00604 · Cited by 1
Self-citationXue, H., Li, X., Rao, G., Hu, F., Zhong, M., Miernikiewicz, P., Qiu, R., Cao, S., Krystyna, D., & Yang, H. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3004009 · Cited by 1
Illouz, M., Wasselin, V., Pál, A., Lewis, C., Foubert, M., Briand, A., Malmsheimer, S., Chalut, C., Korduláková, J., Hatfull, G. F., et al. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00626 · Cited by 1
Self-citation
Metadata
- Authors
- Dedrick, R. M., Smith, B. E., Cristinziano, M., Freeman, K. G., Jacobs-Sera, D., Belessis, Y., Whitney Brown, A., Cohen, K. A., Davidson, R. M., van Duin, D., Gainey, A., Garcia, C. B., Robert George, C. R., Haidar, G., Ip, W., Iredell, J., Khatami, A., Little, J. S., Malmivaara, K., McMullan, B. J., Michalik, D. E., Moscatelli, A., Nick, J. A., Tupayachi Ortiz, M. G., Polenakovik, H. M., Robinson, P. D., Skurnik, M., Solomon, D. A., Soothill, J., Spencer, H., Wark, P., Worth, A., Schooley, R. T., Benson, C. A., & Hatfull, G. F.
- Affiliations
- University of Pittsburgh (US)
- Department of Biological Sciences, University of Pittsburgh , Pittsburgh, Pennsylvania , USA
- UNSW Sydney (AU)
- Inova Fairfax Hospital , Falls Church, Virginia , USA
- Johns Hopkins University (US)
- National Jewish Health (US)
- Division of Infectious Diseases, University of North Carolina , Chapel Hill, North Carolina , USA
- Prisma Health (US)
- Department of Respiratory Disease, Hospital Universitari Vall d’Hebron , Barcelona , Spain
- New South Wales Health Pathology Microbiology, John Hunter Hospital , New Lambton, New South Wales , Australia
- Great Ormond Street Hospital (GB)
- Sydney Children's Hospital (AU)
- Children's Hospital at Westmead (AU)
- Brigham and Women's Hospital (US)
- Miller Children's & Women's Hospital (US)
- Istituto Giannina Gaslini (IT)
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Miller School of Medicine, University of Miami , Miami, Florida , USA
- Wright State University (US)
- University of Helsinki (FI)
- Hunter Medical Research Institute (AU)
- University of California San Diego (US)
- Corresponding author
- Hatfull, Graham F
- ORCID
- Dedrick, Rebekah M
- Smith, Bailey E
- Freeman, Krista G
- Belessis, Yvonne
- Cohen, Keira A
- Davidson, Rebecca M
- Gainey, Andrew
- Haidar, Ghady
- Ip, Winnie
- Iredell, Jonathan
- Khatami, Ameneh
- Little, Jessica S
- McMullan, Brendan J
- Michalik, David E
- Moscatelli, Andrea
- Nick, Jerry A
- Polenakovik, Hari M
- Robinson, Paul D
- Skurnik, Mikael
- Solomon, Daniel A
- Spencer, Helen
- Wark, Peter
- Worth, Austen
- Schooley, Robert T
- Benson, Constance A
- Hatfull, Graham F
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-06-09
- Volume
- 76
- Issue
- 1
- Pages
- 103-112
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC9825826
- OpenAlex
- W4281760779
- Cited by
- 344
- References
- 23
- Citations by year
- 2026: 74 · 2025: 89 · 2024: 91 · 2023: 72 · 2022: 18
- FWCI
- 35.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Howard Hughes Medical Institute (GT12053)
- Cystic Fibrosis Foundation (HATFUL19GO, NICK20Y2-SVC, NICK20Y2-OUT)
- National Heart, Lung, and Blood Institute (K08 HL139994-01)
- Burroughs Wellcome Fund (HL146228, NICK20Y2-SVC and NICK20Y2-OUT)
- NIH (GM131729, AI154546, R01HL146228)
- Jane and Aatos Erkko Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- phage therapy, Mycobacterium abscessus, nontuberculous mycobacterial infection, cystic fibrosis, phage resistance, neutralizing antibodies, phage neutralization, compassionate use, adjunctive therapy
- MeSH terms
- Phage Therapy, Anti-Bacterial Agents, Bacteriophages, Cystic Fibrosis, Pharmaceutical Preparations, Humans, Mycobacterium, Mycobacterium Infections, Nontuberculous, Compassionate Use Trials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.